Are you Dr. Branche?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 732-789-4216
Summary
- Dr. Angela Branche, MD is an infectious disease specialist in Rochester, New York. She is currently licensed to practice medicine in New York and New Jersey. She is affiliated with Strong Memorial Hospital of the University of Rochester.
Education & Training
University of RochesterFellowship, Infectious Disease, 2012 - 2014
NYU Grossman School of Medicine/Brooklyn CampusResidency, Internal Medicine, 2008 - 2011
American University of the Caribbean School of MedicineClass of 2008
Certifications & Licensure
NY State Medical License 2012 - 2026
NJ State Medical License 2011 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
Publications & Presentations
PubMed
- A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection.Angela Branche, Mayur Ramesh, Beverly Francis
Infectious Diseases and Therapy. 2024-12-30 - Histoplasmosis Associated With Bat Guano Exposure in Cannabis Growers: 2 Cases.Paulina Sudnik, Patrick Passarelli, Angela Branche, Ellen Giampoli, Ted Louie
Open Forum Infectious Diseases. 2024-12-01 - Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory Syncytial Virus Hospitalization.Angela R Branche, Ann R Falsey, Lyn Finelli, Edward E Walsh
The Journal of Infectious Diseases. 2024-11-15
Press Mentions
What Can Be Done for Severe RSV Cases in Adults?December 20th, 2024- Real-World Data on the RSV Vaccine for Older AdultsNovember 11th, 2024
- Examine Highlights Significance of RSV Vaccination for High-Risk PopulationsOctober 29th, 2024
- Join now to see all
